Skip to main content

Table 3 General characteristics of kidney transplant recipients, for group 1, 2 and 3

From: Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients

  Group 1 Group 2 Group 3
Characteristic VRE+ VRE - p value VRE+ VRE - p value VRE+ VRE - p value
Gender          
   Male 10(71.4) 58(65.9) 0.769 6(54.5) 35(56.5) 1 4(30.8) 50(54.3) 0.111
Ages, in years 43 ± 14 39 ± 13 0.579 40 ± 10 41 ± 13 0.857 41 ± 11 42 ± 10 0.789
Race          
   White 11(78.6) 61(69.3)   7(63.6) 41(66.1)   12(92.3) 55(59.8)  
   Non-white 3(21.4) 27(30.6) 0.494 7(63.6) 21(33.9) 0.791 1(7.7) 37(40.3) 0.122
Primary renal disease          
   Indeterminate 8(57.1) 45(51.1)   6(54.5) 32(51.6)   7(53.8) 39(42.4)  
   Hypertension 3(21.4) 17(19.3)   3(27.3) 16(25.8)    22(23.9)  
   Glomerulonephritis 3(21.4) 15(17)    6(9.7)   3(23.1) 17(18.5)  
   Diabetes Mellitus   4(4.5)    3(4.8)   1(7.7) 3(3.3)  
   Others   7(8) 0.934 2(18.2) 5(8.1) 0.752 2(15.4) 11(12) 0.195
Pre transplant treatment          
   Hemodialysis 13(92.9) 79(89.8)   11(100) 58(93.5)   10(76.9) 91(98.9)  
   CAPD   7(8)    2(3.2)   2(15.4) 1(1.1)  
   Conservative 1(7.1) 2(2.3) 0.269   2(3.2) 1 1(7.7)   0.006
Kidney donor          
   HLA I and II 6(42.9) 55(62.5)   5(45.5) 36(58.1)   8(61.5) 50(54.3)  
   HLA III and deceased donor 8(57.1) 33(37.5) 0.164 6(54.5) 26(41.9) 0.518 5(38.5) 42(45.7) 0.626
Surgical reexploration 1(7.1) 1(1.1) 0.257 1(9.1) 5(8.1) 1 2(15.4) 4(4.3) 0.16
Mycophenolate mofetil     3(27.3) 31(50) 0.164 4(30.8) 21(22.8) 0.504
OKT3/Thymoglobulin®      7(11.3) 0.585   6(6.5) 1
Methylprednisolone pulse     2(18.2) 20(32.3) 0.486 4(30.8) 32(34.8) 1
Pos-transplantation dialysis 4(28.6) 14(15.9) 0.265   13(21) 0.195 1(7.7) 14(15.2) 0.687
Length of hospitalization in days 7 ± 2 8 ± 5 0.714 18 ± 22 17 ± 15 0.617 31 ± 36 23 ± 20 0.223
Serology          
   Hepatitis C virus 1(7.1) 7(8) 1   1(1.6) 1 4(30.8) 18(21.4) 0.462
   Hepatitis B virus   4(4.5) 1   1(1.6) 1 1(7.7) 1(1.2) 0.236
Antimicrobial drugs     7(63.6) 31(50) 0.519 10(76.9) 69(75) 1
Vancomycin     1(9.1) 1(1.6) 0.28 3(23.1) 6(6.5) 0.081
Ganciclovir      6(9.7) 0.582 2(15.4) 10(10.8) 0.642
  1. CAPD = chronic ambulatory peritoneal dialysis; HLA I = identical human leukocyte antigen;
  2. HLA II = haplo-identical human leukocyte antigen; HLA III = distinct human leukocyte antigen;
  3. Fisher and Student t tests were utilized for mean age and length of hospitalization;
  4. Values are expressed as mean ± SD or N (%).